MedTrace Logo

Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis

NCT03138317 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-11

No results posted yet for this study

Summary

Study was designed to evaluate efficacy of autologous platelet rich plasma (PRP) injections guided by ultrasound for treatment of knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

PRP

This group will receive a knee injection with 6 ml of platelet rich plasma (PRP)

BIOLOGICAL

Plasma

This group will receive a knee injection with 6 ml of plasma.

BIOLOGICAL

Placebo

This group will receive a knee injection with 6 ml saline solution.

Sponsors & Collaborators

  • RDO Laboratory

    collaborator UNKNOWN

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2018-05-30
Completion
2018-05-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03138317 on ClinicalTrials.gov